UNASSIGNED:关于体力活动(PA)是否与儿科人群的身心健康有关,迄今尚未达成共识。为了进一步探索他们的联系,我们的研究通过系统评价和随机对照研究(RCTs)的荟萃分析评估了PA对儿童和青少年身心健康的影响.
未经评估:几个数据库(Webofscience,PubMed,Embase,Cochrane中央对照试验登记册,CINAHL)从开始到第一次进行搜索,2020年12月没有语言限制。
UNASSIGNED:初步确定了38,236条记录,有1,255名参与者的31项纳入研究最终符合我们的纳入标准。所有这些都表现出总体质量偏倚的相对低-中等风险.关于心理健康,PA的管理,与对照组相比,导致儿童和青少年自闭症谱系障碍(ASD)[标准平均差(SMD)=-0.50,置信区间(CI):-0.87,-0.14)]和抑郁症(SMD=-0.68,CI:-0.98,-0.38)的中度改善。同样,在肥胖中观察到显著结果(SMD=-0.58,CI:-0.80,-0.36).注意缺陷多动障碍(ADHD)没有显着差异(SMD=-0.29,CI:-0.59,0.01)。
未经评估:总而言之,PA可能对患有ASD的儿童和青少年有有益的影响,抑郁和肥胖;尽管如此,没有足够的证据证实其在ADHD中的疗效.需要更大规模的基于人群的随机对照试验来探索它们之间更可靠的证据。
UNASSIGNED: No consensus on whether physical activity (PA) is related to physical and mental health among pediatric population remains has been reached to date. To further explore their association, our study assessed the effect of PA on physical and mental health of children and adolescents through a systematic
review and meta-analysis of randomized controlled studies (RCTs).
UNASSIGNED: Several databases(Web of science, PubMed, Embase, Cochrane Central register of controlled trials, CINAHL) were searched from inception to 1st, December 2020 without language restrictions.
UNASSIGNED: 38,236 records were identified primitively and 31 included studies with 1,255 participants eventually met our inclusion criteria, all of which exhibited a relatively low-moderate risk of bias of overall quality. In regard to mental health, the administration of PA, compared with the control group, led to moderate improvements in Autism Spectrum Disorder(ASD)[Standard mean difference (SMD) = -0.50, Confidence interval(CI): -0.87, -0.14)] and depression(SMD = -0.68, CI: -0.98, -0.38) among children and adolescents. Similarly, significant result was observed in obesity (SMD = -0.58, CI: -0.80, -0.36). No significant differences were observed in Attention deficit hyperactivity disorder (ADHD) (SMD = -0.29, CI: -0.59, 0.01).
UNASSIGNED: Altogether, PA may have a beneficial effect on children and adolescents with ASD, depression and obesity; nevertheless, there is insufficient evidence to confirm its efficacy in ADHD. More large-scale population based randomized controlled trials are needed to explore more reliable evidence between them.